Day Two (14th May 2025) - CET/CEST (Cent Europe Summer, GMT+2)
- Geoffrey Pot - General Manager Operations, Site Head, Takeda
- Michael Butler - Principal Investigator, Cell Technology, NIBRT
- Sjoerd Van der Ent - Director Innovation, Koppert
To drive down the cost of goods, biomanufacturers are striving towards maximizing facility utilization, increasing process efficiency, and maintaining a robust supply chain—all without compromising the quality of the final product.
Designed specifically for the hydration of powdered media, feeds, or buffers, the Oceo Rover single-use system delivers consistent solutions on demand in less than half the time of conventional processes. In this session, you will learn how to transform your bioprocessing operations with the first alternative system for media feed and buffer preparation. The Oceo Rover will be demonstrated together with chemically defined media from FUJFILM Irvine Scientific to help you achieve greater efficiencies.
Discover how the Oceo Rover:
- Delivers bioprocessing solutions for both process development and manufacturing, in the upstream and downstream environment, and across multiple modalities
- Hydrates and sterilizes media, feeds, or buffers as a single-unit operation
- Provides repeatable and scalable results using prepacked, single-use cartridges with our chemically defined media portfolio
- Improves environmental, health, and safety considerations and eliminates the risk of cross-contamination via a self-contained system
- Features access to world-class support to help you identify the ideal hydration protocol and optimize your workflows
- Guy Matthews - Director Single Use Technology, FUJIFILM Irvine Scientific
- Thibaut Angevin - Director CMC Proteins, BioNTech SE
- Cleo Kontoravdi - Professor, Imperial College London
- Rui Oliveira - Full Professor at NOVA University Lisbon, School of Science and Engineering Universidade Nova de Lisboa
- Julian Hitzler - Senior Expert Science & Technology, Drug Substance Development, Novartis Pharma
- Lisa-Marie Harlevi - R&T Scientist, Luxembourg Institute of Science and Technology (LIST)
- Weitao Jia, Ph.D. - Director, Pre-Pivotal Biologics Analytical Development and Product Characterization, Gilead Sciences
- Hans-Rainer Voelger - Senior Scientist, Roche Diagnostics GmbH
- Petra Sebastian - Senior Scientist, Biopharmaceutical Product Development Bioanalytical Sciences, CSL Innovation GmbH
Spotlight Presentation – Calling all Technology Thought Leaders!
Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.
Contact us today to learn more: Partners@informaconnectls.com
- Kyle Grant - Director of Vector Production, Voyager Therapeutics
Limitations of viral vectors & need for alternatives
Emerging non-viral delivery tech:
- LNPs, exosomes, CPPs
How novel approaches/systems can aid in:
- Safety, reduced immunogenicity, larger payloads
Utilizing new systems for existing pipelines
Analytical challenges associated with characterisation and ensuring the safety/efficacy of non-viral delivery systems
- Bernd Giebel - Founder & CTO, Exosla Therapeutics
- Lior Shaltiel - CEO, NurExone Biologic
- Ryan Farley - Scientist II, Mesenbio Ltd
Join us in the Exhibit Hall for Live Labs.
You'll be taken on a tour of the hall to meet and engage with our exhibitors, hear quick-fire presentations, and into cutting-edge advancements from the exhibitors you visit - don't miss out!
- Veronique Chotteau, PhD - Professor Mammalian Cell-based Bioprocess Technology, KTH - Royal Institute of Technology
Cell culture media are complex mixture that are critical to ensure the robust production of biopharmaceutical products. Cell culture media quality is however dependent of multiple parameters such as raw material quality and preparation process. While protocols are in place at the biopharmaceutical site as well as at the raw material manufacturer to ensure reproducible preparation, there is to date little technology available to verify that the composition of the medium produce is as expected. This gap lies within the fact that media composition is very heterogenous comprising compounds in very large ranges of concentrations from nM to M and very different chemical properties including metals, salts, organic compounds as well as polymers and proteins. This study shows how we can come closer to closing this gap with an on-line fluorescence-based method for the monitoring of cell culture media preparation. We will show the characterization of the method including sensitivity and scale up as well as the challenges we face for implementation in commercial facilities.
- Amandine Calvet - Associate Head of Laboratory, Boehringer Ingelheim
- Thibaut Angevin - Director CMC Proteins, BioNTech SE
- Thomas Berger, MSc - PhD student, Department of Biosciences and Medical Biology, University of Salzburg
- David Ausländer, PhD - Associate Director, Novartis Pharma AG
- Stefano Menegatti - Associate Professor, North Carolina State University
Cross-team collaboration: integrate sustainability principles across the downstream spectrum
Industry collaboration to drive sustainability across the biopharma industry
The Regulatory Landscape: Navigating EMA and MHRA requirements and view for Sustainable Solutions
Minimizing biological load in waste streams: strategies and best practices
The Role of Innovation: developing new technologies and approaches for a greener future
The importance of facility design for achieving sustainable manufacturing goals
- Weitao Jia, Ph.D. - Director, Pre-Pivotal Biologics Analytical Development and Product Characterization, Gilead Sciences
- A Representative from BioPhorum - -, BioPhorum
- Christian Witz - CEO, SimVantage GmbH
- Dieter Palmberger - CTO, bespark*bio
- Guido Moll - Assistant Coordinator EU-H2020 ATMP & GMP Projects, Charité, Universitätsmedizin Berlin, Germany
- Alexander Hackel - Scientist in Medical Research | Founder, Klinik für Rheumatologie und klinische Immunologie, Universitätsklinikum Schleswig-Holstein (UKSH), University of Lübeck | Ammy Diagnostics (ammy.ai)
Explore groundbreaking research, meet the poster presenters and BPI Editors, plus find out who has won the poster competition (a free ticket to next year's event!)
*For your poster to be entered into the poster competition, please submit your abstract by 31st March 2025 and PDF poster by 14th April*
- Jens Traenkle - Global Head of Process Control and Lab Automation, Bayer Pharma